PARSIPPANY, N.J. and EWING, N.J., April 26, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) and Antares Pharma, Inc.

PARSIPPANY, N.J. and EWING, N.J., Dec. 8, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) and Antares Pharma, Inc. (NYSE Amex: AIS) today announced that the U.S.

Equity Research for top traded penny stocks: Cheniere Energy (AMEX:LNG), Golden Star (AMEX:GSS), Antares Pharma (AMEX:AIS). More reports for Intel (NASDAQ:INTC), Apple (NASDAQ:AAPL) & Level 3 Communications (NASDAQ:LVLT).

Equity Research for top traded penny stocks: Antares Pharma (AMEX:AIS), Ladenburg Thalmann Financial (AMEX:LTS), Gastar Exploration (USA) (AMEX:GST). More report for Apple (NASDAQ:AAPL), Netflix (NASDAQ:NFLX), Applied Materials (NASDAQ:AMAT)

PARSIPPANY, N.J. and EWING, N.J., July 11, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) and Antares Pharma, Inc. (NYSE Amex: AIS) today announced an exclusive licensing agreement for Watson to commercialize Antares' topical oxybutynin gel product in the U.S. and Canada.